FIC20260008I1
(fi )
2026-03-05
tsuranoloni ja sen farmaseuttisesti hyväksyttävät suolat
FIC20260001I1
(fi )
2026-01-15
Oletsarseeni ja sen farmaseuttisesti hyväksyttävät suolat
NO2021012I1
(no )
2021-03-18
avapritinib and pharmaceutically acceptable salts thereof
FR21C1059I2
(fr )
2022-12-02
Compositions pharmaceutiques
EP3091008A4
(en )
2017-06-28
Kinase inhibitor and use thereof
EP2879708A4
(en )
2016-03-16
ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES
EP3063691A4
(en )
2016-11-02
DYNAMIC DE-IDENTIFICATION AND ANONYMITY
EP2968992B8
(en )
2020-01-15
Eutectic formulations of cyclobenzaprine hydrochloride and mannitol
EP3060561A4
(en )
2017-07-05
Strigolactone formulations and uses thereof
BR112015001838A2
(pt )
2017-07-04
composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
DK2844286T3
(da )
2020-05-18
Lyofiliserede og vandige anti-CD40-antistofformuleringer
EP2968993A4
(en )
2016-08-24
MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS
BR112015001459A2
(pt )
2017-07-04
anticorpos anti-kit e usos dos mesmos.
RU2016118771A3
(en )
2018-07-10
Co-crystals and pharmaceutical compositions comprising the same
EP2953618A4
(en )
2016-11-30
MANIPULATION-SAFE PHARMACEUTICAL FORMULATIONS
BR112016007386A2
(pt )
2017-08-01
derivados alcalinos bicíclicos e usos dos mesmos
EP3068443A4
(en )
2017-08-16
Residualizing linkers and uses thereof
EP3064491A4
(en )
2017-03-29
Sulfonamide derivative and medicinal use thereof
IL262797B
(en )
2020-09-30
Preparation and use of a composition for prevention and mitigation of the effects of radiation
EP3049389A4
(en )
2017-04-19
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
BR112016011430A2
(pt )
2017-09-12
agentes anticâncer e preparação dos mesmos.
EP3049077A4
(en )
2017-02-15
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
EP2994457A4
(en )
2016-09-28
RADIOMINDER PHARMACEUTICAL FORMULATIONS
EP2879711A4
(en )
2016-03-16
ANTI-ETBR ANTIBODIES AND IMMUNOCONJUGATES
IL242355B
(en )
2020-11-30
Cannabidiol for the prevention and treatment of graft-versus-host disease